meetings, events and conference coordinators, inc. hotel ... · 4:45 pm – 5:00 pm round table...

HOTEL INFORMATION

REGISTRATION FORM

2:20 pm – 2:35 pm Round Table Discussion and Q & A session Speakers: Thigpen, Benedetto

2:35 pm – 3:15 pm Patient Advocacy Program. Sponsored by Bonnie Addario Lung Cancer Foundation (BALCF) Moderator: Edgardo S. Santos3:15 pm – 3:30 pm Coffee Break & Visit Exhibits

3:15 pm – 5:00 pm Gastrointestinal Tumors Session Moderator: Caio Max Rocha Lima 3:15: pm – 3:45 pm Novel Advances and New Combinations to Treat Biliary and Pancreas Cancers: What’s new? Caio Max Rocha Lima

3:45 pm – 4:15 pm Standard of Care in the Management of mCRC and how to decide based on Genomic Profile the best therapeutic option Annelisa Couthino

4:15 pm – 4:45 pm Interventional Oncology in Gastrointestinal Malignancies Govindarajan Narayanan

4:45 pm – 5:00 pm Round Table Discussion and Q & A Session Speakers: Caio Max Rocha Lima, Annelisa Couthino and Govindarajan Narayanan. 5:00 pm Meeting adjourns for the day.

Sunday, January 31st, 2016

7:00 am – 8:00 am Registration Opens & Visit Exhibits

8:00 am – 8:40 am Breakfast Symposia (non CME)

8:40 am – 10:05 am Hematology Malignancies Session Moderator: Eduardo M. Sotomayor

8:40 am – 9:05 am New Challenges in the Treatment of Multiple Myeloma Sergio Giralt

9:05 am – 9:30 am Targeted Therapy for Non-Hodgkin’s Lymphomas and CLL Eduardo M. Sotomayor

9:30 am – 9:55 am High Risk Myelodysplasia and Leukemia Rami Komrokji

9:55 am – 10:05 am Round Table Discussion and Q & A session Speakers: Sergio Giralt, Eduardo M. Sotomayor and Rami Komrokji

10:05 am – 10:20 am Coffee Break & Visit Exhibits

10:20 am – 11:40 pm Lung Cancer Session Moderator: Luis E. Raez 10:20 am – 10:45 am Chemotherapy and Targeted Therapy for Squamous Cell Carcinoma (SQCC) of the Lung Luis E. Raez

10:45 am – 11:10 am Actionable Mutations in Non-Small Cell Lung Cancer (NSCLC) Edgardo S. Santos

11:10 am – 11:35 am Check-Point Inhibitors: Modern Immunotherapy for Lung cancer Jioty Patel

11:35 pm – 11:45 pm Round Table Discussion and Q & A session Speakers: Luis E. Raez, Edgardo S. Santos and Jioty Patel

11:45 am – 12:45 pm Lunch Symposia (non CME)

12:45 pm – 1:00 pm Coffee Break and Visit Exhibits

1:00 pm – 2:15 pm Breast Cancer Section Moderator: Henry Gomez 1:00pm – 1:25 pm Blockades and Barricades in the HER Family Hope Rugo

1:25 pm – 1:50 pm Genomics and Predictive biomarkers in breast cancer: What do we have today and what the future will bring for us? Mark Pegram

1:50 pm – 2:15 pm Metastatic Chemotherapy and Hormone Therapy for Breast Cancer Vicente Valero

2:15 pm – 2:35 pm Round Table Discussion and Q & A session Speakers: Hope Rugo, Mark Pegram and Vicente Valero

2:35pm Closing Remarks

The Conrad Hilton Hotel Miami 1395 Brickell Avenue Miami, FL 33131 Telephone: 305-503-6585 or 1-800-CONRADS Website: http://conradhotels1.hilton.com

Discover the luxury of the Conrad Miami, the premier hotel in South Florida, combining the ultimate hotel service and the latest technological advancements with the fashion sensibilities of downtown Miami. Located in the innovatively designed structure of concave glass and steel, in the heart of the city’s financial district, the Conrad Miami hotel overlooks Biscayne Bay in Florida. The Conrad Miami has quick and easy access to many attractions in downtown Miami, including South Beach, Coconut Grove and Key Biscayne and is also just 15 minutes from the Miami International Airport.

The hotel is offering special rates during this conference of $299 Deluxe City View; $329 Deluxe Bay View plus tax, European plan (no meals). The cut off date to make reservations is January 4th, 2016, after this date reservations are subject to hotel availability.

Make your reservations by calling 305-503-6585 and identify you as attending the “Miami Cancer Meeting” group code “MEC” or using the link http://resweb.passkey.com/go/13thannual

Meetings, Events and Conference Coordinators, Inc.P.O. Box 430376Miami, FL 33243-0376

_____________PRST STD

US Postage PAID

Miami, FLPermit No. 1429

13TH ANNUAL MIAMI CANCER MEETING (MCM):

“New Horizons in Treating Patients with Cancer: The Saga of Personalized Medicine”

January 29-31, 2016Conrad Hilton Hotel

Miami, Florida

PROGRAM AGENDA Continued...

Miami, Florida

13TH ANNUAL MIAMI CANCER MEETING (MCM): “New Horizons in Treating Patients with Cancer: The Saga of Personalized Medicine”

Fees: $225 - Physicians $ 90 - Residents, Fellows, Nurses & Allied Health Professionals $275 - Professionals from the Pharmaceutical or Laboratory Industry

Registration fee includes all day admission to the Friday evening, Saturday, and Sunday scientific presentations. Refunds must be provided in writing prior to December 20th, 2015. After the December 20th deadline any cancellation will include a $50 administrative charge. Register online at www.meccinc.com

Register online at www.meccinc.com

For more information contact:CONFERENCE MANAGEMENTMECC (Meetings Events & Conference Coordinators, Inc.)1550 S Dixie Highway, Suite 202, Coral Gables, FL 33146Telephone: 305/663-1628 Office Fax: 305/675-2718Teri Valls, Executive Director email: [email protected]

Or visit our website at www.meccinc.com

REGISTRATION

13th Annual Miami Cancer Meeting (MCM): “New Horizons in Treating Patients with Cancer: The Saga of Personalized Medicine”

January 29-31, 2016Conrad Hilton Hotel, Miami, FL

Register online at www.meccinc.com or Mail to: MECC, Inc. 1550 S Dixie Hwy #202, Coral Gables, FL 33146 or FAX to 305/675-2718.

Name __________________________________________________________________________ Degree __________________________

Address ___________________________________________________________________________________________________________

City _________________________________________________ State ______________________ Zip _____________________________

Telephone (_____)_____________________________________________ Fax (_____) __________________________________________

Email address _____________________________________________________________________________________________________

License #______________________________________________________ State _______________________________________________

Specialty _________________________________________________________________________________________________________

Type of Practice: o Private o Academic o Hospital o Resident/Fellow Registration fee: $ 225 - Physicians $ 90 - Residents, Fellows, Nurses and Allied Health Professionals $ 275 - Professionals from the Pharmaceutical or Laboratory Industry

I authorize MECC to charge my credit card i/a/o $______ for registration of this course using the following credit card.

Name on Card ________________________________________________________________ Exp. Date ___________________________

Card number _________________________________________________________________ CVV ________________________________

Authorized signer __________________________________________________________________________________________________

If you require special assistance or have specific dietary requirements, please contact MECC, Inc. no later than January 4th, 2016 via email at [email protected]. Sponsored by

The Medical Educator Consortium

Eileen Butler, RN, MSN, OCN, CPHONDina Dumercy, Pharm.D., BCOPJessica MacIntrye, ARNP, NP-C, OCNDaniel Petrylak, M.D.

Bruno Pacheco Pereira, M.D.Luis E. Raez, M.D., FACP, FCCPCaio Max S. Rocha Lima, M.D.Edgardo S. Santos, M.D., FACP

Educational Committee

Luis E. Raez, M.D, FACP, FCCPMedical DirectorMemorial Cancer InstituteDirector of Clinical Oncology ResearchMemorial Health Care SystemClinical Associate Professor of MedicineHerbert Wertheim College of MedicineFlorida International UniversityMiami, Florida

Caio Max S. Rocha Lima, M.D. Hematology and OncologyAssociate Cancer Center Director for Translational Research Gibbs Cancer Center & Research InstituteCMO Guardian Research Network Spartanburg Healthcare System Spartanburg, SC

Edgardo S. Santos Castillero, M.D., FACPMedical Director of Cancer ResearchThoracic and Head and Neck Cancer ProgramsEugene & Christine Lynn Cancer InstituteAssociate Professor of Clinical Biomedical ScienceCharles E. Schmidt College of MedicineFlorida Atlantic UniversityBoca Raton, FL

Program Directors

Friday, January 29th, 2016:5:00 pm – 7:30 pm Registration Open & Visit Exhibits

5:30 pm – 5:40 pm Welcome and Introduction Luis E. Raez

5:40 pm – 7:50 pm Supportive Care and Palliative Therapy Session Moderator: Dina Dumercy 5:40 pm – 6:10 pm Management of Chemotherapy Induced Side-Effects (Anemia, Neutropenia and Nausea & Vomiting) Jessica MacIntyre

6:10 pm – 6:40 pm Treatment of Bone Metastasis and Hypercalcemia Eriberto Marques, Jr.

6:40 pm – 7:10 pm Targeted Therapy and Immunotherapy: Adverse Reactions in Cancer Patients Adrienne Vazquez

7:10 pm – 7:40 pm Keynote Speaker: New Immunotherapy Agents in Oncology. Christian Rolfo

7:40 pm – 7:50 pm Round Table Discussion and Q & A Session Speakers: Jessica MacIntyre, Adrienne M. Vazquez, Eriberto Marques Jr, and Christian Rolfo Cervetto

7:50 pm – 9:00 pm Symposia Dinner (non CME)

Saturday, January 30th, 20166:30 am – 8:00 am Registration Opens & Visit Exhibits

8:00 am – 8:40 am Breakfast Symposium (non CME)

8:40 am – 10:30 am Brain Tumors, Head & Neck Cancer and Melanoma Session Moderator: Brian Hunis

8:40 am – 9:10 am Malignant Brain Tumors: From Chemotherapy to Targeted Agents and Immunotherapy Gordana Vlahovic 09:10 am – 9:10 am – 09:40 am What is Next in SCCHN? Still Chemotherapy and Radiation? Are We Making Progress in Personalized Medicine? Edgardo S. Santos

9:40 am – 10:10 am How to Choose the Best Treatment for Metastatic Melanoma Patients? Molecular Profiling and More Jose Lutzky

10:10 am – 10:30 am Round Table Discussion and Q & A session Speakers: Gordona Vlahovic, Edgardo S. Santos and Jose Lutzky

10:45 am – 12:00 pm Genitourinary Malignancies Section Moderator: Edgardo S. Santos

10:45 am – 11:15 am Target Therapy for Renal Cell Carcinoma: How Can We Customize Treatment for Each Patient? Primo Lara, Jr. 11:15 am – 11:45 am Systemic Therapy for Metastatic Prostate Cancer: How has it evolved from Hormonal Therapy to New Targeted Agents? Daniel Petrylak

11:45 am – 12:00 pm Round Table Discussion and Q & A session Speakers: Primo Lara, Jr. and Daniel Petrylak

12:00 pm – 1:00 pm Lunch Symposia (non-CME)

1:20 pm – 2:35 pm Gynecologic Malignancies and Sarcomas Session Moderator: Luis E Raez 1:20 pm – 1:50 pm Gynecologic Malignancies James Thigpen

1:50 pm – 2:20 pm Chemotherapy and Targeted Therapy for Soft Tissue Sarcomas Pasquale W. Benedetto

Educational CommitteeEileen Butler, R.N., MSN. OCN, CPHON

Dina Dumercy, Pharm.D., BCOP

Jessica MacIntrye, ARNP, NP-C

Bruno Pacheco Pereira, M.D.

Daniel Petrylak, M.D.

Luis E. Raez, M.D., FACP, FCCP

Caio Max S. Rocha Lima, M.D.

Edgardo S. Santos Castillero, M.D., FACP

Distinguished FacultyPasquale W. Benedetto, M.D.Professor of MedicineDirector, Hematology/Oncology Fellowship ProgramUniversity of Miami/Sylvester Comprehensive Cancer CenterMiami, FL

Eileen A. Butler, R.N., MSN, OCN, CPHONOncology Nurse EducatorSylvester Comprehensive Cancer CenterUniversity of Miami Miller School of MedicineMiami, FL

Anelisa Coutinho, M.D. Division of Gastrointestinal OncologyClinica Assistencia Muldiciplinar em Oncologia (AMO)Salvador, Bahia, Brazil Dina Dumercy, Pharm.D., BCOPClinical Coordinator OncologyMemorial Cancer InstitutePharmacy DepartmentMemorial Healthcare SystemHollywood, FL

Sergio A. Giralt, M.D.Chief, Adult Bone Marrow Transplant Service; Melvin Berlin Family Chair in Multiple MyelomaMemorial Sloan Kettering Cancer CenterNew York, NY

Henry Gomez Moreno, M.D.President, Peruvian Oncology Medical SocietyAttending Physician and Chair, Breast Cancer GroupNational Cancer of Institute (INEN)Lima, Peru

Brian Hunis, M.D.Director of Head & Neck Cancer and QualityMemorial Cancer InstituteClinical Associate Professor of MedicineHerbert Wertheim College of MedicineFlorida International UniversityHollywood, FL

Rami Komrokji, M.D.Clinical Director, Associate Member, Department of Malignant HematologyH Lee Moffitt Cancer Center & Research InstituteTampa, Florida

Primo Lara Jr., M.D.Professor of MedicineUniversity of California DavisSchool of MedicineAssociate Director for Translational ResearchUniversity of California DavisComprehensive Cancer CenterSacramento, CA

Jose Lutzky, M.D.Co-Chief, Hematology & OncologyDirector, Mount Sinai Melanoma ProgramMount Sinai Medical Center Miami, FL

Jessica MacIntyre, ARNP, NP-CSylvester Comprehensive Cancer CenterUniversity of Miami Miller School of MedicineMiami, FL

Eriberto Marques Jr., M.D.Medical Director of Santa Agueda HospitalDepartment of Medical OncologyMember of SBOC/SLACOMRecife-PE, Brazil

Raj Narayanan, M.D.Chief of Vascular andInterventional RadiologyAssociate Professor of Clinical RadiologyDepartment of RadiologySylvester Comprehensive Cancer CenterUniversity of Miami Miller School of MedicineMiami, FL

Bruno Pacheco Pereira, M.D.Medical Director Multihemo/Multionco Hospital Santa Joana Pernambuco University-UPERecife, Brazil

Jyoti Patel, M.D.Leader Thoracic Oncology ProgramAssociate Professor, Medicine Hematology Oncology DivisionFeinberg School of MedicineChicago, IL

Mark Pegram, M.D.Professor of MedicineDirector of the Breast Cancer ProgramCo-Director of Molecular Therapeutic ProgramStanford UniversityPalo Alto, CA

Daniel Petrylak, M.D.Director, Genitourinary Oncology Research ProgramCo-Director, Signal Transduction ProgramYale Comprehensive Cancer CenterYale School of MedicineNew Haven, CT

Christian Rolfo Cervetto, M.D., Ph.D.Head of Unit Phase I - Early Clinical TrialsDirector of Clinical Trial Management ProgramOncology Department, University Hospital Antwerp, Belgium

Hope Rugo, M.D.Professor of MedicineDirector, Breast Oncology and Clinical Trials EducationUniversity of California San FranciscoHelen Diller Family Comprehensive Cancer CenterSan Francisco, CA

Edgardo S. Santos Castillero, M.D., FACPMedical Director of Cancer ResearchLynn Cancer Institute Thoracic and Head and Neck Cancer ProgramsAssociate Professor of Clinical Biomedical SciencesFlorida Atlantic UniversityBoca Raton, Florida

Eduardo Sotomayor, M.D.Director, George Washington University Cancer CenterProfessor of MedicineGeorge Washington University School of Medicine & Health SciencesWashington, DC.

James T. Thigpen, M.D.Professor-Clinical and Division Director of HematologyOncology, HematologyThe University of Mississippi Medical CenterJackson, MS

Vicente Valero, M.D.Professor, and Deputy Chairman Breast Medical Oncology DepartmentClinical Director, The Morgan Welch Inflammatory Breast Cancer Research Program and ClinicAssociate Director, Nellie B. Connally Breast CenterThe University of Texas M.D. Anderson Cancer CenterHouston, TX

Adrienne M. Vazquez, MSN, ACNP-BC, AOCNPMemorial Sloan Kettering Cancer CenterNew York, NY

Gordana Vlahovic, M.D., MHSAssociate Professor of Medicine/OncologyThe Preston Robert Tisch Brain Tumor Center at DukeDuke University Medical CenterDurham, NC

CONFERENCE DESCRIPTION

This is a 2-day course designed for medical oncologists, hematologists, radiation oncologists, surgical oncologists, physician assistants (PA), advanced registered nurse practitioners (ARNP), oncology nurses, registered pharmacists, pharmacy technicians, and radiation therapists. General practitioners (internal medicine and family medicine) will have the benefit of review standard of care and new developments in cancer management. Residents in training and fellows from these specialties are encouraged to attend.

Topics in solid tumors and hematological malignancies will be reviewed; that will include topics in breast cancer, lung cancer, gastrointestinal (GI) malignancies, genitourinary (GU) cancers, gynecologic malignancies, head and neck cancers, melanoma, and hematological malignancies such as multiple myeloma, CLL and non-Hodgkin’s lymphoma, and myelodysplastic syndrome. There will also be a special session devoted to the area of supportive care in oncology, with emphasis on bone metastasis, malignant hypercalcemia, and management of chemotherapy and immunotherapy-related side effects.

The areas of focus for this conference will include the current standards of care in the treatment of all aforementioned malignancies and new developments in these areas of cancer care. There will be much emphasis on molecular diagnosis and individualization of cancer therapy based on molecular profiles.

Presentations from latest national (AACR 2015, ASCO 2015 and ASH 2016) and international forums (ESMO 2015 and WCLC 2015) meetings will be discussed and guidelines of cancer care will be emphasized. The participants in the meeting will have the opportunity not only to learn, review, and understand the state-of-the-art management in cancer care but also engage in personal interaction with our panel of experts in these subjects during our question and answer sessions.

CONFERENCE OBJECTIVES Upon completion of this course attendees will be able to:

1) Understand the latest advances in chemotherapy and immunotherapy options available for lung cancer, breast cancer, GI malignancies, GU malignancies, melanoma, brain tumors, head and neck cancer as well as hematological malignancies including multiple myeloma, NHL, MDS, and CLL.

2) Evaluate the current standards of care in the treatment of a variety of solid and hematologic malignancies.

3) Discuss risks and benefits when combined modality of treatment is delivered to patients who have localized malignant processes (i.e., NSCLC, head and neck, prostate cancer, and others).

4) Apply targeted therapies such as tyrosine kinase inhibitors, antiangiogeneic agents, and other in different tumor types

based on patient’s tumor molecular profile.

5) Identify and treat possible complications which may surge with the use of chemotherapy, targeted treatments, and immunotherapy; the proper use of supportive care.

ACCREDITATIONThe Medical Educator Consortium is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT HOURS (CME)The Medical Educator Consortium, designates this live activity for a maximum of 13 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

NURSING CEUContinuing Education Credit for Nurses will be awarded by the University of Miami Nursing Education Department. A total of 13 CEU’s will be awarded for attendance to all two days of the conference. Participants may attend separately on Friday for 2.8 credit hours, Saturday for 7.2 credit hours, and Sunday 3.0 credit hours. A certificate of completion will be provided to each participant at the end of the conference. Credit will be entered into CE Broker.

PHARMACY CEUThis activity is approved for a total of 13 contact hours of Continuing Education Credit for Pharmacists and Pharmacy Technicians awarded by the University of Miami Sylvester Comprehensive Cancer Center. Participants must attend all day lectures to receive credit for that day. Partial credits are not available. Where credits are approved on a session-by-session basis, participants must attend each session in its entirety to receive complete credit for the session. A certificate of completion will be provided to each participant at the end of the conference. Credit will be entered into CE Broker. UMHC/Sylvester is approved by the Florida Board of Pharmacy as a provider of continuing pharmacy education.

FACULTY DISCLOSURE STATEMENTThe Medical Educator Consortium (MEC) adheres to the ACCME Standards for Commercial Support. All persons that will be in a position to control the content of the CME Activity are required to disclose all relevant financial relationships. Faculty disclosure forms outlining this information will be made available to all participants prior to educational activity. MEC has also implemented a mechanism to identify and resolve all conflicts of interest prior to the education activity being delivered to learners. The source of all support from commercial interests will also be disclosed to learners prior to the beginning of the educational activity.

Educational Committee • Distinguished Faculty 13th Annual Miami Cancer Meeting (MCM): “New Horizons in Treating Patients with Cancer: The Saga of Personalized Medicine”

PROGRAM AGENDA

13th Annual Miami Cancer Meeting (MCM): “New Horizons in Treating Patients with Cancer:

The Saga of Personalized Medicine”